|
|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-03
|
$347,563
|
$347,563
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$73,642
|
$14,728
|
Hickstein, Dennis
|
CCR (NCI)
|
|
|
Zbtb family members in lymphocyte differentiation and function
|
ZIA BC 011429
|
$341,950
|
$341,950
|
Kovalovsky, Damian
|
CCR (NCI)
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
$3,647
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
$1,800
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
$3,769
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
$6,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
$14,546
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
$15,075
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
$78,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Cancer Center NCTN
|
5U10CA180826-03
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
WU-MDACC Inter-Institutional Molecular Imaging Center
|
4P50CA094056-16
|
$1,286,033
|
$154,324
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-03
|
$542,807
|
$27,140
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$2,400
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$81,553
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Web-based Physical Activity Intervention for Children with ALL
|
1R01CA193478-01A1
|
$937,623
|
$937,623
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Weakened spindle checkpoint in vivo: a cause of aneuploidy and cancer in FA?
|
1F30CA200227-01A1
|
$27,801
|
$27,801
|
CERABONA, DONNA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
3U10CA180833-02S1
|
$100,000
|
$5,000
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-03
|
$1,649,280
|
$82,464
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Vorinostat for GVHD prevention in unrelated donor myeloblative conditioning BMT
|
5R21CA198776-02
|
$168,563
|
$84,282
|
CHOI, SUNG
|
UNIVERSITY OF MICHIGAN
|
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
4R01CA044722-26
|
$203,601
|
$203,601
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-03
|
$9,808
|
$490
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
6U10CA180847-04
|
$410,211
|
$20,511
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Validation of the Pre-BCR Signaling Complex in pre-B ALL Cell Model by Two-Color Single Particle Tracking and Peptidomimetic Inhibition
|
5F31CA192848-02
|
$30,343
|
$30,343
|
ERASMUS, MICHAEL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
Validation and Development of WEE1 as a therapeutic target in AML
|
4R01CA172385-04
|
$316,213
|
$316,213
|
PORTER, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-03
|
$645,976
|
$16,149
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-02S1
|
$50,000
|
$1,250
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-03
|
$1,192,600
|
$23,852
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-03
|
$402,343
|
$402,343
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
5R42CA168107-03
|
$344,638
|
$172,319
|
MCLAUGHLIN, JEFFERY
|
RADIANT CREATIVE GROUP, LLC
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$571,941
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$5,400
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$3,375
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
3U54CA096297-14S1
|
$217,227
|
$43,445
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
4U54CA096297-14
|
$1,467,170
|
$293,434
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia
|
1R21CA197441-01A1
|
$167,475
|
$167,475
|
RAO, DINESH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Unlocking the Therapeutic Potential of Retinoic Acid in Acute Myeloid Leukemia
|
1R21CA202488-01A1
|
$200,318
|
$200,318
|
SWORDS, RONAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S6
|
$12,771
|
$3,959
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S1
|
$113,625
|
$35,224
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S2
|
$246,024
|
$76,267
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S3
|
$123,494
|
$38,283
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S4
|
$163,814
|
$50,782
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
5P30CA118100-12
|
$2,246,011
|
$696,263
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S1
|
$198,450
|
$11,907
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S2
|
$499,325
|
$29,960
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
4P30CA046592-28
|
$6,209,909
|
$372,595
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
2P30CA134274-09
|
$2,259,773
|
$225,977
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S1
|
$124,964
|
$12,496
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S2
|
$200,219
|
$20,022
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S3
|
$629,550
|
$62,955
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Total relevant funding to Leukemia for this search: $241,005,895
|
